Abzena, a U.K.-based pharma services company, appears to be on an acquisition tear of late, saying it plans to buy a second U.S.-based company in as many months.
Roche will close four plants around the world and lay off 1,200 people as it moves to new technology for manufacturing small molecule drugs. It says it will build a late-stage technical development and launch facility in Switzerland for targeted, high-potency drugs.
POPULAR COMMENT THREADS
South Africa-based Ascendis Health has acquired a 23,000-square-foot manufacturing facility as part of its $24.6 million deal for the pharmaceutical business of Akacia Healthcare.
Synerlab, a French pharmaceutical manufacturer, has purchased Spain-based contract development and manufacturing company Alcala Farma for an undisclosed amount.
Strides Shasun has resumed limited production at its Cuddalore API plant in India following a fire last week that killed one worker.
William Scully, one of two owners of Medical Device King based in New York, was convicted on charges that he sold more than $17 million worth of fake or unapproved drugs that were manufactured overseas.
Novo Nordisk, the Danish maker of insulin, said all of its global manufacturing facilities will run on electricity generated from renewable sources by 2020.
Germany's Merck KGaA has for some years been taking steps to cash in on the growing population in emerging markets of people needing treatment for diabetes and associated conditions, sometimes building plants to make its diabetes treatments locally. Working through a joint venture, a plant is starting production in North Africa.
From Our Sister Sites
Siemens plans 7,000+ layoffs after disappointing healthcare performance Following a 13% reduction in profit at Siemens Healthcare during the previous quarter, the conglomerate is reportedly planning...
Sweden's Lund University is forming a med tech accelerator with an emphasis on digital health.